• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-31、瘙痒与血液系统恶性肿瘤

IL-31, itch and hematological malignancies.

作者信息

Di Salvo Eleonora, Allegra Alessandro, Casciaro Marco, Gangemi Sebastiano

机构信息

Department of Veterinary Sciences, University of Messina, 98168, Messina, Italy.

Division of Hematology, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University of Messina, 98125, Messina, Italy.

出版信息

Clin Mol Allergy. 2021 Jun 12;19(1):8. doi: 10.1186/s12948-021-00148-7.

DOI:10.1186/s12948-021-00148-7
PMID:34118946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8199420/
Abstract

Pruritus is one of the most common symptoms experienced by neoplastic patients. The pathogenesis of neoplastic itch is complex and multifactorial and could be due to an unbalanced production of humoral mediators by altered immune effector cells. IL-31 is a pro-inflammatory cytokine produced by CD4 + T helper cells. The aim of this review was to evaluate the role of this Th2 cytokine and its receptor IL-31RA, in the onset of neoplastic pruritus. We analysed scientific literature looking for the most relevant original articles linking IL-31to itch in oncologic diseases. Interleukin-31 seems to be a main itch mediator in several hematologic disease such as Cutaneous T cells lymphomas. In these patients IL-31 was positively linked to itch level, and IL-31 matched with disease stage. IL-31 seems to play an important role in the signalling pathway involved in pruritus, but it is also suggested to play a proinflammatory and immunomodulatory role which could play a part in the progression of the neoplastic disease. Further studies will be fundamental in facing pruritus in oncologic patients, since this problem compromise their quality of life worsening an already critic picture.

摘要

瘙痒是肿瘤患者最常见的症状之一。肿瘤性瘙痒的发病机制复杂且多因素,可能是由于免疫效应细胞改变导致体液介质产生失衡。白细胞介素-31(IL-31)是一种由CD4 +辅助性T细胞产生的促炎细胞因子。本综述的目的是评估这种Th2细胞因子及其受体IL-31RA在肿瘤性瘙痒发病中的作用。我们分析了科学文献,寻找将IL-31与肿瘤疾病瘙痒联系起来的最相关原始文章。白细胞介素-31似乎是几种血液系统疾病(如皮肤T细胞淋巴瘤)中的主要瘙痒介质。在这些患者中,IL-31与瘙痒程度呈正相关,且IL-31与疾病分期相符。IL-31似乎在瘙痒相关的信号通路中起重要作用,但也有人认为它具有促炎和免疫调节作用,这可能在肿瘤疾病的进展中起作用。进一步的研究对于解决肿瘤患者的瘙痒问题至关重要,因为这个问题会降低他们的生活质量,使本已危急的情况更加恶化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb51/8199420/c4473828735b/12948_2021_148_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb51/8199420/c4473828735b/12948_2021_148_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb51/8199420/c4473828735b/12948_2021_148_Fig1_HTML.jpg

相似文献

1
IL-31, itch and hematological malignancies.白细胞介素-31、瘙痒与血液系统恶性肿瘤
Clin Mol Allergy. 2021 Jun 12;19(1):8. doi: 10.1186/s12948-021-00148-7.
2
Itch in dermatomyositis: the role of increased skin interleukin-31.特应性皮炎患者皮肤组织中白介素-31 的表达及意义
Br J Dermatol. 2018 Sep;179(3):669-678. doi: 10.1111/bjd.16498. Epub 2018 Jun 21.
3
Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the Skin.皮肤T细胞淋巴瘤与瘙痒:白细胞介素-31及其受体在皮肤中的表达
Acta Derm Venereol. 2016 Nov 2;96(7):894-898. doi: 10.2340/00015555-2417.
4
Interleukin-31 and Pruritic Skin.白细胞介素-31与瘙痒性皮肤
J Clin Med. 2021 Apr 28;10(9):1906. doi: 10.3390/jcm10091906.
5
Interleukin-31 is overexpressed in skin and serum in cutaneous T-cell lymphomas but does not correlate to pruritus.白细胞介素-31在皮肤T细胞淋巴瘤的皮肤和血清中过表达,但与瘙痒无关。
Postepy Dermatol Alergol. 2022 Feb;39(1):81-87. doi: 10.5114/ada.2020.100824. Epub 2020 Nov 13.
6
Pruritus as a Distinctive Feature of Type 2 Inflammation.瘙痒作为2型炎症的一个显著特征。
Vaccines (Basel). 2021 Mar 23;9(3):303. doi: 10.3390/vaccines9030303.
7
Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus.P 物质和神经激肽 1 受体是治疗慢性瘙痒的新靶点。
Br J Dermatol. 2019 Nov;181(5):932-938. doi: 10.1111/bjd.18025. Epub 2019 Jun 6.
8
The molecular basis for IL-31 production and IL-31-mediated itch transmission: from biology to drug development.IL-31 产生和 IL-31 介导的瘙痒传递的分子基础:从生物学到药物开发。
Int Immunol. 2021 Nov 25;33(12):731-736. doi: 10.1093/intimm/dxab065.
9
Interleukin-31, a Potent Pruritus-Inducing Cytokine and Its Role in Inflammatory Disease and in the Tumor Microenvironment.白细胞介素-31,一种强效的瘙痒诱导细胞因子及其在炎症性疾病和肿瘤微环境中的作用。
Adv Exp Med Biol. 2021;1290:111-127. doi: 10.1007/978-3-030-55617-4_8.
10
Cynomolgus monkey model of interleukin-31-induced scratching depicts blockade of human interleukin-31 receptor A by a humanized monoclonal antibody.白细胞介素-31 诱导搔抓的食蟹猴模型描述了人源化单克隆抗体对人白细胞介素-31 受体 A 的阻断作用。
Exp Dermatol. 2018 Jan;27(1):14-21. doi: 10.1111/exd.13236. Epub 2017 Apr 10.

引用本文的文献

1
Canine interleukin-31 binds directly to OSMRβ with higher binding affinity than to IL-31RA.犬白细胞介素-31与OSMRβ直接结合,其结合亲和力高于与IL-31RA的结合亲和力。
3 Biotech. 2023 Sep;13(9):302. doi: 10.1007/s13205-023-03724-7. Epub 2023 Aug 14.
2
The Anti-Cancer Effect of Cinnamon Aqueous Extract: A Focus on Hematological Malignancies.肉桂水提取物的抗癌作用:聚焦血液系统恶性肿瘤
Life (Basel). 2023 May 12;13(5):1176. doi: 10.3390/life13051176.
3
Proteomic-Based Platelet Activation-Associated Protein SELP May Be a Novel Biomarker for Coagulation and Prognostic in Essential Thrombocythemia.

本文引用的文献

1
The Impact of Immunological Checkpoint Inhibitors and Targeted Therapy on Chronic Pruritus in Cancer Patients.免疫检查点抑制剂和靶向治疗对癌症患者慢性瘙痒的影响。
Biomedicines. 2020 Dec 22;9(1):2. doi: 10.3390/biomedicines9010002.
2
The ambiguous pruritogenic role of interleukin-31 in cutaneous T-cell lymphomas in comparison to atopic dermatitis: a review.白细胞介素-31在皮肤T细胞淋巴瘤与特应性皮炎中瘙痒原性作用的比较:综述
Postepy Dermatol Alergol. 2020 Jun;37(3):319-325. doi: 10.5114/ada.2020.96260. Epub 2020 Jul 16.
3
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.
基于蛋白质组学的血小板活化相关蛋白SELP可能是原发性血小板增多症凝血和预后的新型生物标志物。
J Clin Med. 2023 Jan 30;12(3):1078. doi: 10.3390/jcm12031078.
针对伴有瘙痒的特应性皮炎的 Nemolizumab 与局部治疗药物的试验。
N Engl J Med. 2020 Jul 9;383(2):141-150. doi: 10.1056/NEJMoa1917006.
4
Follicular lymphoma.滤泡性淋巴瘤。
Nat Rev Dis Primers. 2019 Dec 12;5(1):83. doi: 10.1038/s41572-019-0132-x.
5
Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study.尼莫利珠单抗治疗中重度特应性皮炎患者的随机、II 期、长期扩展研究。
J Allergy Clin Immunol. 2018 Oct;142(4):1121-1130.e7. doi: 10.1016/j.jaci.2018.03.018. Epub 2018 May 10.
6
IL-33/IL-31 Axis: A Potential Inflammatory Pathway.IL-33/IL-31 轴:一种潜在的炎症途径。
Mediators Inflamm. 2018 Mar 11;2018:3858032. doi: 10.1155/2018/3858032. eCollection 2018.
7
Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis.白细胞介素-31 和白细胞介素-31 受体:特应性皮炎的新治疗靶点。
Exp Dermatol. 2018 Apr;27(4):327-331. doi: 10.1111/exd.13533.
8
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients.霍奇金淋巴瘤患者血浆和淋巴结中白细胞介素-31及胸腺基质淋巴细胞生成素的表达
Oncotarget. 2017 Jul 28;8(49):85263-85275. doi: 10.18632/oncotarget.19665. eCollection 2017 Oct 17.
9
The IL-31/IL-31 receptor axis: general features and role in tumor microenvironment.IL-31/IL-31 受体轴:一般特征及其在肿瘤微环境中的作用。
J Leukoc Biol. 2017 Sep;102(3):711-717. doi: 10.1189/jlb.3MR0117-033R. Epub 2017 Apr 13.
10
Cynomolgus monkey model of interleukin-31-induced scratching depicts blockade of human interleukin-31 receptor A by a humanized monoclonal antibody.白细胞介素-31 诱导搔抓的食蟹猴模型描述了人源化单克隆抗体对人白细胞介素-31 受体 A 的阻断作用。
Exp Dermatol. 2018 Jan;27(1):14-21. doi: 10.1111/exd.13236. Epub 2017 Apr 10.